Evidence map›Paper›PMID 20127859›Full record

ArticleInternational journal of cancer2010

Oral benzo[a]pyrene-induced cancer: two distinct types in different target organs depend on the mouse Cyp1 genotype.

Zhanquan Shi, Nadine Dragin, Marian L Miller, Keith F Stringer, Elisabet Johansson, Jing Chen, Shigeyuki Uno, Frank J Gonzalez, Carlos A Rubio, Daniel W Nebert

Open access · bronzeAbstract read
In one paragraph

Article in International journal of cancer, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Pharmacokinetics of [Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2018
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Mitochondrial targeting of mouse NQO1 and CYP1B1 proteins.Biochemical and biophysical research communications · 2013
    Article
  16. Article
  17. Article
  18. Polycyclic aromatic hydrocarbons and digestive tract cancers: a perspective.Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews · 2011
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Zhanquan ShiDepartment of Environmental Health and Center for Environmental Genetics, University of Cincinnati Medical Center, Cincinnati, OH 45267-0056, USA.
Nadine Dragin
Marian L Miller
Keith F Stringer
Elisabet Johansson
Jing Chen
Shigeyuki Uno
Frank J Gonzalez
Carlos A Rubio
Daniel W Nebert
University of Cincinnati Medical Center · USUniversity of Cincinnati · USCincinnati Children's Hospital Medical Center · USKarolinska Institutet · SENational Institutes of Health · US

Funding

REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY RESEARCHP30ES006096 · NIEHS · UNIVERSITY OF CINCINNATI · PI YADAV, JAGJIT S · 1992 to 2022
$35.4M
Xenobiotic receptorsZIABC005562 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI GONZALEZ, FRANK J · 2009 to 2025
$26.9M
PAHs: Balance of Detoxication vs Metabolic ActivationR01ES014403 · NIEHS · UNIVERSITY OF CINCINNATI · PI NEBERT, DANIEL W. · 2006 to 2009
$1.4M
NIEHS NIH HHS P30 ES006096NIEHS NIH HHS R01 ES014403
6 · The paper itself

Abstract

Benzo[a]pyrene (BaP) is a prototypical polycyclic aromatic hydrocarbon (PAH) found in combustion processes. Cytochrome P450 1A1 and 1B1 enzymes (CYP1A1 and CYP1B1) can both detoxify PAHs and activate them to cancer-causing reactive intermediates. Following high dosage of oral BaP (125 mg/kg/day), ablation of the mouse Cyp1a1 gene causes immunosuppression and death within ∼28 days, whereas Cyp1(+/+) wild-type mice remain healthy for >12 months on this regimen. In this study, male Cyp1(+/+) wild-type, Cyp1a1(-/-) and Cyp1b1(-/-) single-knockout and Cyp1a1/1b1(-/-) double-knockout mice received a lower dose (12.5 mg/kg/day) of oral BaP. Tissues from 16 different organs-including proximal small intestine (PSI), liver and preputial gland duct (PGD)-were evaluated; microarray cDNA expression and >30 mRNA levels were measured. Cyp1a1(-/-) mice revealed markedly increased CYP1B1 mRNA levels in the PSI, and between 8 and 12 weeks developed unique PSI adenomas and adenocarcinomas. Cyp1a1/1b1(-/-) mice showed no PSI tumors but instead developed squamous cell carcinoma of the PGD. Cyp1(+/+) and Cyp1b1(-/-) mice remained healthy with no remarkable abnormalities in any tissue examined. PSI adenocarcinomas exhibited striking upregulation of the Xist gene, suggesting epigenetic silencing of specific genes on the Y-chromosome; the Rab30 oncogene was upregulated; the Nr0b2 tumor suppressor gene was downregulated; paradoxical overexpression of numerous immunoglobulin kappa- and heavy-chain variable genes was found-although the adenocarcinoma showed no immunohistochemical evidence of being lymphatic in origin. This oral BaP mouse paradigm represents an example of "gene-environment interactions" in which the same exposure of carcinogen results in altered target organ and tumor type, as a function of just 1 or 2 globally absent genes.

Indexed as

AdenocarcinomaAdministration, OralAnimalsAryl Hydrocarbon HydroxylasesBenzo(a)pyreneCarcinoma, Squamous CellCytochrome P-450 CYP1A1Cytochrome P-450 CYP1B1FemaleGenotypeInbreedingIntestinal NeoplasmsIntestine, SmallMaleMiceMice, Inbred C57BLAryl Hydrocarbon HydroxylasesBenzo(a)pyreneCyp1b1 protein, mouseCytochrome P-450 CYP1A1Cytochrome P-450 CYP1B1

Identifiers

PMID20127859
PMCPMC2917638
OpenAlexW2040652515

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.